slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,129
Current window 7,741-7,770
Pages 2,605
Rows per page 30
Component
7,741-7,770 of 78,129
16
HBT Financial | Results Presentation Deck | 36 slidesHBT Financial | Results Presentation Deck | 36 slides · HBT Financial
Conference presentation Investor relations Beat · The Breakthrough3 hits
18
Includes a donut chart for 4Q 2023 composition and two stacked bar charts for revenue trends.Heartland Financial USA | Results Presentation Deck | 35 slides · HTLF
Conference presentation Investor relations Beat · Satisfaction3 hits
27
The top chart is a waterfall bridge showing the reconciliation of the allowance balance from 12/31/2022 to 12/31/2023.Heartland Financial USA | Results Presentation Deck | 35 slides · HTLF
Conference presentation Investor relations Beat · Action3 hits
10
Slide 10 of a presentation, includes detailed commentary on asset sensitivity reduction strategies.Hilltop Holdings | Results Presentation Deck | 22 slides · Hilltop Holdings
Conference presentation Investor relations Beat · What IsLoop · Hypothesis Test3 hits
18
The slide uses donut charts to visualize portfolio composition.HomeStreet | Results Presentation Deck | 36 slides · HomeStreet
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain3 hits
08
Includes flow cytometry plots and bar charts showing efficacy.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction3 hits
17
Includes comparative data points for CAR-T characteristics.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Solution & Approach3 hits
38
The slide uses a combination of biological pathway diagrams, pharmacokinetic data, and efficacy metrics to demonstrate the therapeutic advantage of IMX-110.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps3 hits
49
The slide uses three distinct bar charts to compare IMX-110 performance against standard of care or competitor drugs in preclinical mouse models.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps3 hits
52
Includes clinical trial data visualization with PFS (Progression Free Survival) and PD/PR thresholds.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps3 hits
56
Includes comparative size diagram of IMX-111 vs IgG antibody, bar chart of GLUT1 expression by tissue, box plot of GLUT1 expression by stage, and Kaplan-Meier survival curve.Immix Biopharma | Investor Presentation Deck | 64 slides · Immix Biopharma
Deck Investor relations Beat · Impact & Next Steps3 hits
27
The slide uses a mix of donut charts and a bar chart to visualize portfolio composition and risk exposure.Independent Bank Corp | Results Presentation Deck | 30 slides · Independent Bank Corp
Conference presentation Investor relations 3 hits
19
Includes three donut charts and a list of key highlights regarding deposit stability and collateralization.KeyCorp | Results Presentation Deck | 30 slides · KeyCorp
Conference presentation Investor relations Beat · DevelopmentLoop · Before After3 hits
24
Includes footnotes for data definitions.KeyCorp | Results Presentation Deck | 30 slides · KeyCorp
Conference presentation Investor relations Beat · DevelopmentLoop · Before After3 hits
11
The slide uses a combination of stacked bar charts and standard bar charts to illustrate financial performance metrics.Lazard | Investor Presentation Deck | 46 slides · Lazard
Conference presentation Investor relations Beat · Market SizeLoop · Cost Of Inaction3 hits
25
Includes study design details (n=55, female C57BL/6 mice) and statistical significance markers for treatment groups.Matinas BioPharma | Investor Presentation Deck | 29 slides · Matinas BioPharma
Pitch deck Investor relations 3 hits
18
The slide uses preclinical data to demonstrate efficacy superiority over a market-leading GLP-1 agonist.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle3 hits
19
The slide uses three distinct chart types to demonstrate efficacy and metabolic impact.NeuroBo Pharmaceuticals | Investor Presentation Deck | 25 slides · NeuroBo Pharmaceuticals
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle3 hits
34
The slide presents data across five quarters for various metrics, including MSR portfolio statistics, net return components, and loan servicing volumes.New York Community Bancorp | Results Presentation Deck | 42 slides · New York Community Bancorp
Conference presentation Investor relations 3 hits
29
The slide uses three distinct chart types to demonstrate competitive advantages in potency, PK, and selectivity.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 3 hits
39
Includes three distinct preclinical assay results: In Vitro Activity, Selectivity Index, and Brain Penetrance.Nuvalent | Investor Presentation Deck | 41 slides · Nuvalent
Pitch deck Investor relations 3 hits
30
Includes specific pharmacological data points for NVL-520 vs competitors like Crizotinib, Entrectinib, Lorlatinib, Taletrectinib, and Repotrectinib.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 3 hits
40
The slide uses three distinct chart types to demonstrate superiority in three key pharmacological areas.Nuvalent | Investor Presentation Deck | 42 slides · Nuvalent
Pitch deck Investor relations 3 hits
11
The slide presents three separate line charts showing tumor growth inhibition over time for different cell lines (RL95-2, KLE, SNG-M).Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction3 hits
20
Includes two distinct experimental setups: in vitro proliferation assays and in vivo bioluminescence imaging (BLI) tumor growth studies.Nuvectis Pharma | Investor Presentation Deck | 25 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · TractionLoop · Voice Of Customer3 hits
25
Includes regulatory disclosures regarding interest rate modeling and methodology.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · Market Size3 hits
26
Includes a list of key credit metrics and a footnote regarding non-GAAP financial measures.Pathward Financial | Results Presentation Deck | 34 slides · Pathward Financial
Conference presentation Investor relations Beat · Market Size3 hits
15
Includes three distinct charts tracking credit metrics over time.South Plains Financial | Results Presentation Deck | 25 slides · South Plains Financial
Conference presentation Investor relations Beat · FinancialsLoop · Cost Of Inaction3 hits
22
The slide displays three distinct bar charts comparing financial and operational performance metrics over time.Tesla | Results Presentation Deck | 32 slides · Tesla
Conference presentation Investor relations 3 hits
23
The slide displays three distinct bar charts comparing financial and operational metrics over time.Tesla | Results Presentation Deck | 32 slides · Tesla
Conference presentation Investor relations 3 hits